Skip to Content
Merck
All Photos(1)

Documents

33156-U

Supelco

TMSI+PYRIDINE, 1:4 (Sylon™ TP)

Synonym(s):

1-(Trimethylsilyl)imidazole - Pyridine mixture, Silylating mixture VII, TMSI+Pyridine

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

CAS Number:
8077-35-8
MDL number:
MFCD00284770
UNSPSC Code:
12000000
PubChem Substance ID:
329754466
NACRES:
NA.22

packaging

pkg of 1 × 25 mL

concentration

(TMSI+Pyridine, 1:4)

SMILES string

c1ccncc1.C[Si](C)(C)n2ccnc2

InChI

1S/C6H12N2Si.C5H5N/c1-9(2,3)8-5-4-7-6-8;1-2-4-6-5-3-1/h4-6H,1-3H3;1-5H

InChI key

PFVKFOIOKNIZKY-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

TMSI+PYRIDINE, 1:4 (Sylon™ TP) may be used as a derivatization reagent for the measurement of liver and plasma precursor sterols using gas chromatography coupled with mass spectrometry while investigating the dual-action glycogenolysis/cholesterolgenesis inhibitors that act through inhibition of both glycogen phosphorylase and CYP51.

Legal Information

Sylon is a trademark of Sigma-Aldrich Co. LLC

related product

Product No.
Description
Pricing

Pictograms

FlameExclamation mark
GHS02,GHS07

Signal Word

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

3 - Flammable liquids

WGK

WGK 3

Flash Point(F)

62.6 °F - closed cup

Flash Point(C)

17 °C - closed cup

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
LC25334V
LC22431V
LC21918V
LC19751V
LC16071V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

H James Harwood et al.
Journal of lipid research, 46(3), 547-563 (2004-12-18)
Diabetic dyslipidemia requires simultaneous treatment with hypoglycemic agents and lipid-modulating drugs. We recently described glycogen phosphorylase inhibitors that reduce glycogenolysis in cells and lower plasma glucose in ob/ob mice (J. Med. Chem., 41: 2934, 1998). In evaluating the series prototype
Comparison between Solvent Extraction Using Gas Chromatography Mass Spectrometry Triple Quadrupole (GCMS-QQQ) of Cholesterol and Cholesterol Oxidation Derivatives
A.R. Alina
Middle-East Journal of Scientific Research 13, 13, 43-48 (2013)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service